Heather Lipkind, MD
DownloadHi-Res Photo
About
Titles
Professor Adjunct
Biography
Dr. Lipkind graduated from Wesleyan University where she received a B.A. in Biology. She went on to earn her M.D. degree from Weill Cornell Medical College in New York City. She completed her residency in OB/GYN at New York University. She completed her Maternal-fetal Medicine fellowship at Columbia University in 2006 and her Master’s in Clinical Epidemiology from the Mailman School of Public Health during her Fellowship. Dr. Lipkind worked as a Perinatal Epidemiology Consultant at the New York City Department of Health and Mental Hygiene from 2006-2010. She is interested in outcomes research and population based epidemiology.
Education & Training
- Fellow
- Columbia University College of Physicians and Surgeons (2006)
- MS
- Mailman School of Public Health (2005)
- Fellow
- Brown University (2004)
- Resident
- New York University School of Medicine (2003)
- MD
- Cornell University Medical College (1999)
- BA
- Wesleyan University (1994)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Heather Lipkind's published research.
Publications Timeline
A big-picture view of Heather Lipkind's research output by year.
Annalies Denoble, MD, MSc
Ariadna Forray, MD
Jennifer Nelson
Kimberly Yonkers, MD
Moeun Son, MD, MSCI, FACOG
Olga Grechukhina, MD
14Publications
5Citations
Publications
COVID-19 Vaccination in the First Trimester and Major Structural Birth Defects Among Live Births
Kharbanda E, DeSilva M, Lipkind H, Romitti P, Zhu J, Vesco K, Boyce T, Daley M, Fuller C, Getahun D, Jackson L, Williams J, Zerbo O, Weintraub E, Vazquez-Benitez G. COVID-19 Vaccination in the First Trimester and Major Structural Birth Defects Among Live Births. JAMA Pediatrics 2024, 178 PMID: 38949821, PMCID: PMC11217887, DOI: 10.1001/jamapediatrics.2024.1917.Peer-Reviewed Original ResearchCitationsAltmetricConceptsStructural birth defectsLive-born infantsFirst-trimesterBirth defectsCOVID-19 vaccineLive birthsRetrospective cohort study of singleton pregnanciesStudy of singleton pregnanciesVaccine exposureMessenger RNA COVID-19 vaccineMessenger RNAFirst-trimester vaccinationMRNA COVID-19 vaccinePrevent pregnancy complicationsRetrospective cohort studyStabilized inverse probability weightsElectronic health dataNeural tube defectsMedical record reviewMultisite cohort studyLMP dateVaccine Safety DatalinkCOVID-19 vaccine dosesSingleton pregnanciesEligible pregnanciesNonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes
Son M, Riley L, Staniczenko A, Cron J, Yen S, Thomas C, Sholle E, Osborne L, Lipkind H. Nonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes. JAMA Network Open 2024, 7: e2419268. PMID: 38976271, PMCID: PMC11231799, DOI: 10.1001/jamanetworkopen.2024.19268.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsRespiratory syncytial virusNeonatal intensive care unitPreterm birthWeeks gestationRisk of HDPPerinatal outcomesLogistic regression modelsIncreased riskPregnant individualsPrenatal vaccinationSmall-for-gestational age birth weightNeonatal intensive care unit admissionCohort studyIncreased risk of PTBOdds ratioIncreased risk of HDPRisk of preterm birthRespiratory syncytial virus seasonRespiratory syncytial virus vaccineRetrospective observational cohort studyNeonatal respiratory distressVaccination statusMultivariate logistic regression modelObservational cohort studyCox regression modelsDoes reversible postpartum contraception reduce the risk of pregnancy condition recurrence? A longitudinal claims-based study from Maine
Ahrens K, Palmsten K, Lipkind H, Ackerman-Banks C, Grantham C. Does reversible postpartum contraception reduce the risk of pregnancy condition recurrence? A longitudinal claims-based study from Maine. Annals Of Epidemiology 2024, 96: 58-65. PMID: 38885800, DOI: 10.1016/j.annepidem.2024.06.001.Peer-Reviewed Original ResearchConceptsDays of deliveryPostpartum contraceptive useInterpregnancy intervalPregnancy conditionsReversible contraceptionPrenatal depressionRisk of prenatal depressionContraceptive useShort interpregnancy intervalAssociated with recurrenceRisk of recurrenceAssociated with lower riskLog-binomial regression modelsModerately effective methodsEstimate risk ratiosHypertensive disordersIndex pregnancyPostpartum contraceptionPregnancy deliveryClaims-based studyGestational diabetesIntrauterine deviceIntrapartum periodContraceptive initiationPregnancyCoronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink.
Denoble A, Vazquez-Benitez G, Sheth S, Ackerman-Banks C, DeSilva M, Zhu J, Daley M, Getahun D, Klein N, Vesco K, Irving S, Nelson J, Williams J, Hambidge S, Donahue J, Weintraub E, Kharbanda E, Lipkind H. Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink. Obstetrics And Gynecology 2024 PMID: 38843526, DOI: 10.1097/aog.0000000000005632.Peer-Reviewed Original ResearchAltmetricConceptsVaccine Safety DatalinkAntepartum stillbirthVaccine Safety Datalink sitesLive birthsCOVID-19 vaccineVaccine dosePregnancy start dateRisk of severe morbidityRisk of stillbirthConditional logistic regressionCase-control studyVaccine manufacturersSingleton pregnanciesGestational ageFetal deathPostpartum visitMaternal ageIndex dateSevere morbidityDiagnostic codesPregnancyStillbirthPregnant peopleCOVID-19Logistic regressionAssociation Between Hypertensive Disorders of Pregnancy and Cardiovascular Diseases Within 24 Months After Delivery
Ackerman-Banks C, Lipkind H, Palmsten K, Ahrens K. Association Between Hypertensive Disorders of Pregnancy and Cardiovascular Diseases Within 24 Months After Delivery. Obstetric Anesthesia Digest 2024, 44: 72-73. DOI: 10.1097/01.aoa.0001015964.97203.7e.Peer-Reviewed Original ResearchAltmetricConceptsHypertensive disease of pregnancyIncreased risk of long-term morbidityHypertensive disorders of pregnancyRisk of long-term morbidityDisease of pregnancyDisorders of pregnancyLong-term morbidityImmediate postpartum periodCardiovascular diagnosisHypertensive disordersIncreased riskPostpartum periodHypertensive diseaseCardiovascular diseaseCVD outcomesRisk profilePregnancyMonthsDiagnosisRiskDeliveryAssociationMorbidityReporting Perinatal Substance Use to Child Protective Services: Obstetric Provider Perspectives on the Impact on Care
Kaufman J, Yonkers K, Maltz C, Friedhoff C, Tobon A, Mele A, Tessier-Kay M, Grechukhina O, Lipkind H, Byatt N, Forray A. Reporting Perinatal Substance Use to Child Protective Services: Obstetric Provider Perspectives on the Impact on Care. Journal Of Women's Health 2024 PMID: 38770764, DOI: 10.1089/jwh.2023.0822.Peer-Reviewed Original ResearchConceptsOpioid use disorderProvider perspectiveKey informant interviewsCPS involvementNurse practitionersAffect careObstetric patientsCareInformant interviewsPostpartum patientsReporting requirementsCPS reportsProvidersContent analysisPerinatal individualsUse disorderSocial workersThematic areasPatientsFearNursesMandated reportersObstetriciansPostpartumStaffObstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination
Vesco K, Denoble A, Lipkind H, Kharbanda E, DeSilva M, Daley M, Getahun D, Zerbo O, Naleway A, Jackson L, Williams J, Boyce T, Fuller C, Weintraub E, Vazquez-Benitez G. Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination. Obstetrics And Gynecology 2024, 143: 794-802. PMID: 38626447, PMCID: PMC11090513, DOI: 10.1097/aog.0000000000005583.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsSmall-for-gestational ageMessenger RNA COVID-19 vaccineGestational diabetes mellitusRisk of adverse pregnancy outcomesAdverse pregnancy outcomesPreterm birthGestational hypertensionAdjusted hazard ratiosCOVID-19 vaccine dosesPregnancy outcomesCOVID-19 vaccineAssociated with small-for-gestational ageIncreased risk of adverse pregnancy outcomesVaccine doseRisk of preterm birthMessenger RNARetrospective cohort study of individualsMRNA COVID-19 vaccineWeeks of gestationRetrospective cohort studyHistory of COVID-19Cohort study of individualsVaccine Safety DatalinkSingleton pregnanciesUnexposed pregnanciesAssociation between gestational diabetes and cardiovascular disease within 24 months postpartum
Ackerman-Banks C, Palmsten K, Lipkind H, Ahrens K. Association between gestational diabetes and cardiovascular disease within 24 months postpartum. American Journal Of Obstetrics & Gynecology MFM 2024, 6: 101366. PMID: 38580094, DOI: 10.1016/j.ajogmf.2024.101366.Peer-Reviewed Original ResearchConceptsGestational diabetes mellitusShort-term risks of cardiovascular diseaseRisk of cardiovascular diseaseGestational diabetesChronic hypertensionDiabetes mellitusMonths postpartumIschemic heart diseaseCardiovascular diseaseShort-term riskHeart failureEffect of gestational diabetes mellitusPre-gestational diabetes mellitusIncreased riskEffects of gestational diabetesDecreased risk of heart failureHeart diseaseCerebrovascular disease/strokePre-pregnancy diagnosisGestational age <Pregestational diabetes mellitusRisk of heart failurePremature cardiovascular morbidityLongitudinal population-based studyDevelopment of diabetes mellitusImplementation of virtual group prenatal genetic counseling: a pilot study
Weingarten S, Brockhoff E, Spielman E, Lipkind H, Scholl J. Implementation of virtual group prenatal genetic counseling: a pilot study. American Journal Of Obstetrics & Gynecology MFM 2024, 6: 101327. PMID: 38447675, DOI: 10.1016/j.ajogmf.2024.101327.Peer-Reviewed Original ResearchAltmetricCOVID-19 Prevalence and Trends Among Pregnant and Postpartum Persons in Maine by Rurality and Pregnancy Conditions
Grantham C, Ackerman-Banks C, Lipkind H, Palmsten K, Ahrens K. COVID-19 Prevalence and Trends Among Pregnant and Postpartum Persons in Maine by Rurality and Pregnancy Conditions. Journal Of Maine Medical Center 2024, 6 DOI: 10.46804/2641-2225.1156.Peer-Reviewed Original Research
Clinical Trials
Current Trials
Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)
HIC ID2000028023RoleSub InvestigatorPrimary Completion Date07/31/2022Recruiting ParticipantsGenderFemaleAge18+ yearsSupport Models for Addiction Related Treatment (SMART) Trial of Opioid Use Disorder in Pregnant Women
HIC ID2000027031RoleSub InvestigatorPrimary Completion Date04/28/2023Recruiting ParticipantsGenderFemaleAge18+ yearsChronic Hypertension and Pregnancy (CHAP) Project (CHAP)
HIC ID2000024291RoleSub InvestigatorPrimary Completion Date12/31/2020Recruiting ParticipantsGenderFemaleAge12+ years
Links & Media
News
- May 02, 2022
Major Funding Award Supports Yale Efforts to Address Maternal Health Inequities
- March 17, 2022
Major Funding Award Supports Yale Efforts to Address Maternal Health Inequities
- January 06, 2022Source: Yale Medicine
You’re Pregnant: Is It Safe To Get a COVID-19 Vaccine?
- January 04, 2022Source: YaleNews
COVID-19 Vaccine Does Not Increase Risk of Preterm Birth